Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
NNX 0.035 +0.0% ABX 51.85 −0.7% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.99 +10.5% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.40 −0.5% SGZ 0.045 +0.0% S 0.155 +29.2% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% NNX 0.035 +0.0% ABX 51.85 −0.7% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.99 +10.5% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.40 −0.5% SGZ 0.045 +0.0% S 0.155 +29.2% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0%
Production / Operations Routine +

Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Workplace Drug and Alcohol Testing Clinic

Cannabix Executes Commercial Rollout Amidst Dilution Concerns

By The Northwire Desk — AI Analysis May 04, 2026 · 08:45 BLO · 0.72 Cannabix Technologies Inc.
Executive Summary
  • Cannabix Technologies announced the delivery of its Marijuana Breath Test (MBT) products to a workplace drug and alcohol testing clinic in eastern Canada on May 4, 2026.
  • The product was delivered via an authorized reseller rather than direct sales, targeting commercial companies, government agencies, and individual clients.
  • The MBT hardware includes the Breath Collection Unit (BCU) and Breath Cartridge technologies, utilizing LC-MS analysis for lab-confirmed results.
  • This follows a pattern of commercial deployments established in March 2026 with the launch announcement and April 2026 delivery to a Virginia industrial manufacturing client.
  • The company continues to position breath-based THC testing as an adjunct service for deterrence, post-incident, and fitness-for-duty applications.
Material Impact
  • Incremental Execution: This news confirms the execution of the commercial rollout strategy announced in March 2026 but does not introduce new market data or strategic partnerships beyond what was already disclosed with Omega Laboratories.
  • Revenue Scale: The delivery to a single clinic implies immaterial revenue contribution relative to the company's capital needs and dilution history; it validates the product rather than scaling it significantly.
  • Market Expectations: Given the March launch announcement and April US deployment, this Canadian clinic delivery was anticipated as part of the phased rollout plan. It does not exceed expectations materially.
  • Stock Price Impact: Likely neutral to slightly positive in the short term due to confirmation of sales activity, but unlikely to drive a sustained breakout without evidence of larger contract values or recurring revenue growth.
BLO · Price
Company Overview
  • Flagship Project: Marijuana Breath Test (MBT) system designed to detect recent delta-9 THC use in breath within a 4-hour window using LC-MS analysis.
  • Secondary Product: BreathLogix alcohol screening devices for unmanned, pre-access testing in safety-critical industries (maritime, mining, oil & gas).
  • Development Status: MBT has passed FCC/ISED emissions testing and received peer-reviewed validation in the Journal of Analytical Toxicology (March 2026). Commercial rollout began March 2026.
  • Technology Advantage: Non-invasive collection process distinguishes recent use from historical exposure, addressing a gap left by traditional urine/saliva tests.
Read the original news release →

More from Cannabix Technologies Inc.

Jun 29, 2026 · 08:45

Cannabix scales its breath-based THC and alcohol screening hardware into global mining and industrial sectors, but revenue remains negligible against operating burn.

Production / Operations Jun 15, 2026 · 08:45

Cannabix Technologies Inc.

M&A / Property May 29, 2026 · 08:45

Cannabix Expands Australian Footprint as MBT Certification Progresses Amidst Volatility

Production / Operations May 13, 2026 · 08:45

Cannabix Secures UL/CSA Certs, Clears Path for Gov Tenders Amidst Steady Commercial Rollout

Regulatory Apr 20, 2026 · 08:45

Cannabix Breath Test Gains Traction in US Manufacturing Sector Following Commercial Launch

M&A / Property Apr 01, 2026 · 08:45

Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Virginia based Industrial Manufacturing Client

Production / Operations